|
EP1818331A1
|
|
Process for the preparation of 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole substantially free of sulfone impurity
|
|
EP1798236A1
|
|
Process for the preparation of 3-pyridyl-1-hydroxyethylidene-1,1- biphosphonic acid and hydrated forms thereof
|
|
AU2003247327A1
|
|
Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form
|
|
WO2004106338A1
|
|
Novel crystalline forms of valacyclovir hydrochloride
|
|
AU2002368531A1
|
|
Isolation of dihydropyridine derivative and preparation salts thereof
|
|
WO2004024674A1
|
|
Process for the preparation of bupropion hydrochloride
|
|
EP1513868A1
|
|
Process for the production of lisinopril
|
|
AU2002345524A1
|
|
A process for the production of substituted phenyl ethers
|
|
AU2002345523A1
|
|
Process for the preparation of simvastatin
|
|
EP1390373A1
|
|
Process for the preparation of 4-amino-1-hydroxybutylidene-1, 1-biphosphonic acid
|
